{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T22:30:09Z","timestamp":1721946609264},"reference-count":0,"publisher":"National Institute of Public Health NIH (National Research Institute)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Przegl Epidemiol"],"abstract":"<p><strong>ABSTRACT<\/strong><br \/><strong>AIM OF THE STUDY.<\/strong> To evaluate the main features of epidemiology of tuberculosis (TB) in 2019 in Poland\u00a0and to compare with the situation in the European Union and European Economic Area (EU\/EEA) countries.<br \/><strong>MATERIAL AND METHODS.<\/strong> Analysis of case-based data on TB patients from National TB Register,\u00a0data on anti-TB drug susceptibility in cases notified in 2019, data from Central Statistical Office on deaths\u00a0from tuberculosis in 2018, data from National Institute of Public Health \u2013 National Institute of Hygiene on\u00a0HIV-positive subjects for whom TB was an AIDS-defining disease, data from the report \u201eEuropean Centre for\u00a0Disease Prevention and Control\/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in\u00a0Europe 2021 \u2013 2019 data\u201d.<br \/><strong>RESULTS.<\/strong> In 2019, 5321 TB cases were reported in Poland. The incidence rate was 13.9 cases per 100,000 with\u00a0large variability between voivodeships from 8.0 to 20.0 per 100,000. The number of all pulmonary tuberculosis\u00a0cases was 5075 i.e. 13.2 per 100,000. Pulmonary cases represented 95.4% of all TB cases. In 2019, 246\u00a0extrapulmonary TB cases were notified (4.6% of all TB cases). Pulmonary tuberculosis was bacteriologically\u00a0confirmed in 3926 cases (77.4% of all pulmonary TB cases, the incidence rate 10.2 per 100,000). The number of\u00a0smear-positive pulmonary TB cases was 2565 i.e. 6.7 per 100,000 ( 48.2% of all pulmonary TB cases). In 2019,\u00a0there were 41 cases (18 of foreign origin) with multidrug resistant TB (MDR-TB) representing 1.1% of cases with\u00a0known drug sensitivity.<br \/>The incidence rates of tuberculosis were growing along with the age group from 1.4 per 100,000 among children\u00a0(0-14 years) to 23.9 per 100,000 among subjects in the age group 45-64 years, the incidence rate in the age group\u00a0\u226565 years was 19.8 per 100,000. There were 81 cases in children up to 14 years of age (1.5% of the total) and 48\u00a0cases in adolescents between 15 and 19 years of age \u2013 rates 1.4 and 2.6 per 100,000 respectively. In 2019, there\u00a0were 3897 cases of tuberculosis in men and 1424 in women. The TB incidence in men \u2013 21.0 per 100,000 was 2.9\u00a0times higher than among women \u2013 7.2. The biggest difference in the TB incidence between the two sex groups\u00a0occurred in persons aged 50-54 years \u2013 40.2 vs. 8.1 and in age group 55 to 59 years \u2013 45.1 vs. 9.0. In 2019, there\u00a0were 121 patients of foreign origin among all cases of tuberculosis in Poland (2.3%). In 2018, TB was the cause\u00a0of death for 519 people (mortality rate \u2013 1.4 per 100,000).<br \/><strong>CONCLUSIONS.<\/strong> TB incidence in Poland in 2019 was lower than in the previous year. Differences in incidence\u00a0between voivodships persist. The percentage of TB cases with bacteriological confirmation exceeded 75%,\u00a0more than in EU\/EEA countries (67.1%). In Poland, MDR-TB is less common than the average in the EU\/EEA\u00a0countries. In Poland, the highest incidence rates are found in older age groups. The percentage of children up\u00a0to 14 years of age among all TB patients was 1.5%, lower than the average in EU\/EEA countries (3.9%). The\u00a0incidence of tuberculosis in men is nearly three times as high as in women. The impact of migration on the\u00a0characteristics of tuberculosis in Poland is not substantial. The percentage of foreign-born persons among TB\u00a0patients is low.<\/p>\n<p><strong>STRESZCZENIE<\/strong><br \/><strong>CEL PRACY.<\/strong> Analiza sytuacji epidemiologicznej gru\u017alicy w Polsce w 2019 roku przez por\u00f3wnanie z sytuacj\u0105 w tym przedmiocie w krajach Unii Europejskiej (UE) i Europejskiego Obszaru Gospodarczego (EOG).<br \/><strong>MATERIA\u0141 I METODY.<\/strong> Analiza danych z Krajowego Rejestru Zachorowa\u0144 na Gru\u017alic\u0119 dotycz\u0105cych przypadk\u00f3w zarejestrowanych w 2019 roku, wynik\u00f3w lekowra\u017cliwo\u015bci pr\u0105tk\u00f3w z rejestr\u00f3w laboratoryjnych, danych G\u0142\u00f3wnego Urz\u0119du Statystycznego o zgonach z przyczyny gru\u017alicy (z 2018 roku), danych Narodowego Instytutu Zdrowia Publicznego \u2013 Pa\u0144stwowego Zak\u0142adu Higieny o przypadkach gru\u017alicy jako choroby wska\u017anikowej AIDS oraz raportu Europejskiego Centrum do Spraw Zapobiegania i Kontroli Chor\u00f3b (ang. European Centre for Disease Prevention and Control) o gru\u017alicy w krajach UE\/EOG w 2019 roku.<br \/><strong>WYNIKI.<\/strong> W 2019 roku zarejestrowano w Polsce 5321 przypadk\u00f3w gru\u017alicy. Zapadalno\u015b\u0107 wynosi\u0142a 13,9 na 100 000 (wsp\u00f3\u0142czynniki zapadalno\u015bci r\u00f3\u017cni\u0142y si\u0119 mi\u0119dzy wojew\u00f3dztwami i wynosi\u0142y od 8,0 do 20,0 na 100 000).<br \/>5075 os\u00f3b (95,4% og\u00f3\u0142u) mia\u0142o gru\u017alic\u0119 p\u0142uc \u2013 wsp\u00f3\u0142czynnik 13,2. Chorzy wy\u0142\u0105cznie na gru\u017alic\u0119 pozap\u0142ucn\u0105 \u2013 246, stanowili 4,6% wszystkich zachorowa\u0144. W 3926 przypadkach gru\u017alicy p\u0142uc (77,4%) rozpoznanie by\u0142o potwierdzone bakteriologicznie (10,2 na 100 000). Chorzy na gru\u017alic\u0119 p\u0142uc, w liczbie 2565 (6,7 na 100 000), u kt\u00f3rych pr\u0105tki stwierdzono tak\u017ce w bakterioskopii, stanowili 48,2% wszystkich przypadk\u00f3w gru\u017alicy p\u0142uc.<br \/>41 chorych (1,1% przypadk\u00f3w ze znanymi wynikami lekowra\u017cliwo\u015bci), w tym 18 cudzoziemc\u00f3w, mia\u0142o gru\u017alic\u0119 wielolekooporn\u0105 (ang. multidrug-resistant tuberculosis, MDR-TB). Wsp\u00f3\u0142czynniki zapadalno\u015bci na gru\u017alic\u0119 ros\u0142y od 1,4 u dzieci do lat 14 do 23,9 na 100 000 w grupie wieku 45-64 lata (u os\u00f3b w wieku 65 lat i starszych \u2013 19,8). Zg\u0142oszono 81 zachorowa\u0144 na gru\u017alic\u0119 u dzieci do lat 14 (1,5% og\u00f3\u0142u chorych) i 48 przypadk\u00f3w u m\u0142odzie\u017cy w wieku od 15 do 19 lat \u2013 wsp\u00f3\u0142czynniki odpowiednio 1,4 i 2,6 na 100 000. W 2019 roku zarejestrowano 3897 zachorowa\u0144 u m\u0119\u017cczyzn \u2013 wsp\u00f3\u0142czynnik zapadalno\u015bci 21,0 i 1424 zachorowania u kobiet \u2013 wsp\u00f3\u0142czynnik 7,2. Zapadalno\u015b\u0107 na gru\u017alic\u0119 u m\u0119\u017cczyzn by\u0142a 2,9 razy wi\u0119ksza ni\u017c u kobiet. Najwi\u0119ksza r\u00f3\u017cnica zapadalno\u015bci mi\u0119dzy m\u0119\u017cczyznami i kobietami wyst\u0119powa\u0142a u os\u00f3b w wieku od 50 do 54 lat (40,2 vs. 8,1) i od 55 do 59 lat (45,1 vs. 9,0). Cudzoziemcy (121) stanowili 2,3% og\u00f3\u0142u chorych na gru\u017alic\u0119. W 2018 roku gru\u017alica by\u0142a przyczyn\u0105 zgonu 519 os\u00f3b (wsp\u00f3\u0142czynnik umieralno\u015bci \u2013 1,4 na 100 000).<br \/><strong>WNIOSKI.<\/strong> Zapadalno\u015b\u0107 na gru\u017alic\u0119 w Polsce w 2019 roku by\u0142a mniejsza ni\u017c w roku poprzednim. Nadal stwierdza si\u0119 r\u00f3\u017cnice zapadalno\u015bci mi\u0119dzy wojew\u00f3dztwami. Odsetek przypadk\u00f3w gru\u017alicy z potwierdzeniem bakteriologicznym przekroczy\u0142 75% i by\u0142 wy\u017cszy ni\u017c w krajach UE\/EOG (67,1%). Odsetek zachorowa\u0144 na MDR-TB by\u0142 mniejszy ni\u017c przeci\u0119tny w UE\/EOG. Najwy\u017csze wsp\u00f3\u0142czynniki zapadalno\u015bci stwierdza si\u0119 w Polsce w starszych grupach wieku. Odsetek dzieci w wieku do 14 lat w\u015br\u00f3d og\u00f3\u0142u chorych na gru\u017alic\u0119 wynosi\u0142 1,5%, mniej ni\u017c \u015bredni w krajach UE\/EOG (3,9%). Zapadalno\u015b\u0107 na gru\u017alic\u0119 u m\u0119\u017cczyzn jest w Polsce blisko trzykrotnie wi\u0119ksza ni\u017c u kobiet, u chorych w wieku od 50 do 59 lat pi\u0119ciokrotnie wi\u0119ksza. Wp\u0142yw migracji na obraz gru\u017alicy w Polsce nie jest znacz\u0105cy. Odsetek cudzoziemc\u00f3w w\u015br\u00f3d chorych na gru\u017alic\u0119 jest w Polsce ma\u0142y.<\/p><\/jats:p>","DOI":"10.32394\/pe.75.18","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T13:42:45Z","timestamp":1635169365000},"page":"192-209","source":"Crossref","is-referenced-by-count":2,"title":["Tuberculosis in Poland in 2019"],"prefix":"10.32394","volume":"75","author":[{"given":"M","family":"Korzeniewska-Kose\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Weso\u0142owski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17323","published-online":{"date-parts":[[2021,10,15]]},"container-title":["Przeglad Epidemiologiczny"],"original-title":["Gru\u017alica w Polsce w 2019 roku"],"link":[{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181000-101561","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/pdf-181000-101561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:44:57Z","timestamp":1709887497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.przeglepidemiol.pzh.gov.pl\/Tuberculosis-in-Poland-in-2019,181000,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"alternative-id":["181000"],"URL":"https:\/\/doi.org\/10.32394\/pe.75.18","relation":{},"ISSN":["0033-2100","2545-1898"],"issn-type":[{"value":"0033-2100","type":"print"},{"value":"2545-1898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}